Trial Profile
Study of Secukinumab in Psoriatic Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2018
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 30 Nov 2018 New trial record
- 24 Oct 2018 Results presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting